FindTrial
Sign In

Phase II clinical study of TY-51924 in patients with acute myocardial infarction - Pilot study -

Phase II clinical study of TY-51924 in patients with acute myocardial infarction - Pilot study -

Status
Unknown
Phases
Phase 2
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT2080221349
Enrollment
Unknown
Registered
2011-01-11
Start date
2011-01-11
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute myocardial infarction

Interventions

investigational material(s) Generic name etc : TY-51924 INN of investigational material : Therapeutic category code : 219 Other cardiovascular agents Dosage and Administration for Investigational mat

Sponsors

TOA EIYO LTD.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Acute myocardial infarction

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Safety, Pharmacokinetics—

Secondary

MeasureTime frame
Efficacy—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026